Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by a
constellation of cardiovascular (CV) and non-CV manifestations. Even though CV …

Background Data on long-term cardiovascular outcomes in systemic lupus erythematosus
(SLE) are sparse. Objectives This study sought to examine the long-term risk and prognosis …

Background Although case series suggest a higher burden of cardiovascular risk factors in
patients with systemic lupus erythematosus (SLE) compared with the general population, the …

Systemic lupus erythematosus (SLE) is an autoimmune condition characterized by multi-
organ involvement. The clinical presentation often varies from mild to moderate to severe …

Systemic lupus erythematosus (SLE) is an auto-immune disease of a relapsing-remitting
nature that can cause multiorgan damage depending on several factors, mainly the disease …

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with a strong
female predilection. Cardiovascular morbidity and mortality is a frequent complication …

Introduction SLE is increasingly recognized as an important risk factor for cardiovascular
disease. Premature CAD and several other cardiac manifestations are resulting in significant …

There is a well-known increased risk for cardiovascular disease that contributes to morbidity
and mortality in systemic lupus erythematosus (SLE). Major adverse cardiovascular events …

Systemic lupus erythematosus (SLE) is a chronic and multisystemic autoimmune disorder
which predominantly affecting women. The most common cause of death in SLE patients …

Awareness of the impact of cardiovascular disease on the late morbidity and mortality in
patients with Systemic Lupus Erythematosus (SLE) is increasing. Clinical events secondary …